Genetic Technologies Limited (Nasdaq: GENE) to Ring The Nasdaq Stock Market Closing Bell
06 May 2016 - 12:00AM
What: Genetic Technologies
Limited (Nasdaq:GENE), a molecular diagnostics company specializing
in women’s health, and provider of BREVAGenplus®, a first-in-class,
clinically validated risk assessment test for sporadic breast
cancer, will visit the Nasdaq MarketSite in Times Square.
In honor of the occasion, Eutillio Buccilli, Chief
Executive Officer and Pippa Mann, race car driver in the Verizon
IndyCar Series and BREVAGenplus spokesperson, will ring
the Closing Bell.
Where:Nasdaq MarketSite – 4 Times Square – 43rd
& Broadway – Broadcast Studio
When:Friday, May 6, 2016 – 3:45 p.m. to 4:00
p.m. ET
Genetic Technologies Media Contact:Candice
Knoll Blueprint Life Science Group(415) 375 3340, Ext.
4cknoll@bplifescience.com
Nasdaq MarketSite:Emily Pan(646)
441-5120emily.pan@nasdaq.com
Feed Information:Fiber Line (Encompass
Waterfront): 4463
Gal 3C/06C 95.05 degrees West 18 mhz Lower DL 3811 Vertical FEC
3/4 SR 13.235 DR 18.295411 MOD 4:2:0 DVBS QPSK
Social Media:For multimedia features such as
exclusive content, photo postings, status updates and video of bell
ceremonies, please visit our Facebook
page:http://www.facebook.com/NASDAQ.
For photos from ceremonies and events, please visit our
Instagram page:http://instagram.com/nasdaq
For livestream of ceremonies and events, please visit our
YouTube page:http://www.youtube.com/nasdaq/live
For news tweets, please visit our Twitter
page:http://twitter.com/nasdaq
For exciting viral content and ceremony photos, please visit our
Tumblr page:http://nasdaq.tumblr.com/
Webcast: A live stream of the Nasdaq Closing
Bell will be available at: https://new.livestream.com/nasdaq/live
or http://www.nasdaq.com/about/marketsitetowervideo.asx
Photos: To obtain a hi-resolution photograph of
the Market Close, please go to
http://business.nasdaq.com/discover/market-bell-ceremonies and
click on the market close of your choice.
About Genetic Technologies LimitedGenetic
Technologies is a molecular diagnostics company that offers
predictive testing and assessment tools to help physicians
proactively manage women’s health. The Company’s lead product,
BREVAGenplus®, is a clinically validated risk assessment test for
non-hereditary breast cancer and is first in its class.
BREVAGenplus improves upon the predictive power of the first
generation BREVAGen test and is designed to facilitate better
informed decisions about breast cancer screening and preventive
treatment plans. BREVAGenplus expands the application of BREVAGen
from Caucasian women to include African-Americans and Hispanics,
and is directed towards women aged 35 years or above, who have not
had breast cancer and have one or more risk factors for developing
breast cancer. The Company has successfully launched the first
generation BREVAGen test across the U.S. via its U.S. subsidiary
Phenogen Sciences Inc. and the addition of BREVAGenplus, launched
in October 2014, significantly expands the applicable market. The
Company markets BREVAGenplus to healthcare professionals in
comprehensive breast health care and imaging centres, as well as to
obstetricians/gynaecologists (OBGYNs) and breast cancer risk
assessment specialists (such as breast surgeons). For more
information, please visit www.brevagenplus.com and
www.phenogensciences.com.
About NasdaqNasdaq (Nasdaq:NDAQ) is a leading
provider of trading, clearing, exchange technology, listing,
information and public company services across six continents.
Through its diverse portfolio of solutions, Nasdaq enables
customers to plan, optimize and execute their business vision with
confidence, using proven technologies that provide transparency and
insight for navigating today's global capital markets. As the
creator of the world's first electronic stock market, its
technology powers more than 70 marketplaces in 50 countries, and 1
in 10 of the world's securities transactions. Nasdaq is home to
more than 3,700 listed companies with a market value of
approximately $9.3 trillion and nearly 17,000 corporate clients. To
learn more, visit: nasdaq.com/ambition or business.nasdaq.com.
-NDAQA-
Nasdaq (NASDAQ:NDAQ)
Historical Stock Chart
From Mar 2024 to May 2024
Nasdaq (NASDAQ:NDAQ)
Historical Stock Chart
From May 2023 to May 2024